Clinical trial
A Clinical Trial to Demonstrate the Efficacy of Cangrelor
NCT00305162 · The Medicines Company, Industry · Terminated
Key facts
| NCT number | NCT00305162 |
|---|---|
| Title | A Clinical Trial to Demonstrate the Efficacy of Cangrelor |
| Official title | A Clinical Trial Comparing Cangrelor to Clopidogrel in Subjects Who Require Percutaneous Coronary Intervention (PCI). |
| Acronym | PCI |
| Lead sponsor | The Medicines Company, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Infarction (MI), Acute Coronary Syndromes (ACS) |
| Intervention type | Drug |
| Interventions | Cangrelor (P2Y12 inhibitor), clopidogrel (oral P2Y12 inhibitor), Placebo bolus & placebo infusion, Placebo capsules - end of infusion, Placebo capsules - as soon as possible after randomization |
| Enrollment | 8,882 |
| Start date | Apr 1, 2006 |
| Primary completion | May 1, 2009 |
| Completion | Jun 1, 2010 |
| First posted | Mar 21, 2006 |
| Last update posted | May 8, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: